Neuropeptides in the regulation of brain activity in normal and neurodegeneration
- Authors: Teplyashina E.A1, Olovyannikova R.Y.1, Kharitonova E.V1, Lopatina O.L1, Kutyakov V.A1, Pashchenko S.I1, Pozhilenkova E.A1, Salmina A.B1
-
Affiliations:
- Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
- Issue: Vol 23, No 8 (2020)
- Pages: 3-10
- Section: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/112768
- DOI: https://doi.org/10.29296/25877313-2020-08-01
- ID: 112768
Cite item
Abstract
Keywords
Full Text
About the authors
E. A Teplyashina
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
Email: elenateplyashina@mail.ru
Ph.D. (Biol.), Associate Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry
R. Ya Olovyannikova
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
Email: Olovyannikova2010@yandex.ru
Ph.D. (Biol.), Associate Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry
E. V Kharitonova
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
Email: ekaterinav1201@gmail.com
Ph.D. (Pharm.), Senior Lecturer, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry
O. L Lopatina
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
Email: ol.lopatina@gmail.com
Dr.Sc. (Biol.), Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry
V. A Kutyakov
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
Email: victor-koutjakov@yandex.ru
Ph.D. (Biol.), Associate Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry
S. I Pashchenko
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
Email: psi51@mail.ru
Assistant, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry
E. A Pozhilenkova
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
Email: elena.a.pozhilenkova@gmail.com
Ph.D. (Biol.), Associate Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry
A. B Salmina
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky of the Ministry of Health of the Russian Federation
Email: allasalmina@mail.ru
Dr.Sc. (Med.), Professor, Head of the Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry
References
- Hook V., Lietz C., Podvin S., Cajka T., Fiehn O. Diversity of Neuropeptide Cell-Cell Signaling Molecules Generated by Proteolytic Processing Revealed by Neuropeptidomics Mass Spectrometry. J Am Soc Mass Spectrom. 2018; 29(5): 807-816.
- Bakos J., Zatkova M., Bacova Z., Ostatnikova D. The Role of Hypothalamic Neuropeptides in Neurogenesis and Neurito-genesis. Neural Plast. 2016; 13.
- Van Dam D., Van Dijck A., Janssen L., De Deyn P.P. Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities. Curr Alzheimer Res. 2013; 10(5): 449-68.
- Chen X.Y, Du Y.F, Chen L. Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease. Front. Mol. Neurosci. 2019; 11: 493.
- Горина Я.В., Комлева Ю.К., Лопатина О.Л., Черных А.И., Салмина А.Б. Влияние инсулинорезистентности на нарушение метаболизма глюкозы в миндалине головного мозга при экспериментальной болезни Альцгеймера. Бюллетень сибирской медицины. 2017; 16(4): 106-115
- Комлева Ю.К., Горина Я.В., Черных А.И., Лопатина О.Л., Шабалова А.А., Труфанова Л.В., Оловянникова Р.Я., Ендржеевская-Шурыгина В.Ю., Салмина А.Б. Особенности пролиферации и миграции клеток головного мозга при когнитивном тренинге животных с экспериментальной болезнью Альцгеймера. Бюллетень сибирской медицины. 2016; 6: 1-5
- Do K., Laing B.T., Landry T., Bunner W., Mersaud N., Matsubara T., Li P., Yuan Y., Lu Q., Huang H. The effects of exercise on hypothalamic neurodegeneration of Alzheimer’s disease mouse model. J. Am. Soc. Mass Spectrom; 2018; 13(1).
- Popelovd A., Kdkonovd A., Hrubd L., Kunes J., Maletlnskd L., Zeleznd B. Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells. Physiol. Res. 2018; 67: 339-346.
- Hu K., Harper D.G., Shea S.A., Stopa E.G., Scheer F.A. Non-invasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia. Sci. Rep. 2013; 3: 2229.
- Xiao Z., Cilz N.I., Kurada L., Hu B., Yang C., Wada E., Combs C.K., Porter J.E., Lesage F., Lei S. Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease model. J. Neurosci. 2014; 34: 7027-7042.
- An H., Cho M.H., Kim D.H., Chung S., Yoon S.Y. Orexin impairs the phagocytosis and degradation of amyloid-β fibrils by microglial cells. J. Alzheimers Dis. 2017; 253-261.
- Lee D.Y., Hong S.H., Kim B., Lee D.S., Yu K., Lee K.S. Neuropeptide Y mitigates ER stress-induced neuronal cell death by activating the PI3K-XBP1 pathway. Eur. J. Cell Biol. 2018; 97: 339-348.
- Johansson P., Almqvist E.G., Wallin A., Johansson J.O., Andreasson U., Blennow K., Zetterberg H., Svensson J. Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease. Neurosci. Lett. 2015; 609: 58-62.
- Gabelle A., Jaussent I., Hirtz C., Vialaret J., Navucet S., Grasselli C., Robert P., Lehmann S., Dauvilliers Y. Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process. Neurobiol. Aging. 2017; 53: 59-66.
- Gallone S., Boschi S., Rubino E., De Martino P., Scarpini E., Galimberti, D., Fenoglio C., Acutis P.L., Maniaci M.G, Pinessi L., Rainero I. Is HCRTR2 a genetic risk factor for Alzheimer's disease? Dement. Geriatr. Cogn. Disord. 2014; 38: 245-253.
- Balmus I.M., Ciobica A., Stoica B., Lefter R., Cojocari S., Reznikov A.G. Effects of Oxytocin Administration on Oxidative Markers in the Temporal Lobe of Aged Rats. Neurophysiology. 2019; 51: 18-24.
- Elabd C., Cousin W., Upadhyayula P., Chen R.Y., Chooljian M.S., Li J., Kung S., Jiang K.P., Conboy I.M. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat. Commun. 2014; 10 (5): 4082.
- Jesso S., Ross S., Pell M.D., Pastermak S.H., Mitchell D.G., Kertesz A., Finger E.C. The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain. 2011; 134(9): 2493-501.
- Finger E.C., MacKinley J., Blair M., Oliver L.D., Jesso S., Tartaglia M.C., Borrie M., Wells J., Dziobek I., Pasternak S., Mitchell D.G.V., Rankin K., Kertesz A., Boxer A. Oxytocin for frontotemporal dementia. Neurology. 2015; 84(2): 174-181.
- Tampi R.R., Maksimowski M., Ahmed D., Tampi M.J. Oxytocin for frontotemporal dementia: a systematic review. Ther. Adv. Psychopharmacol. 2017; 7(1): 48-53.